| scholarly article | Q13442814 |
| P2093 | author name string | Wassim Y Almawi | |
| Sameh Sarray | |||
| P2860 | cites work | Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review | Q24804355 |
| Interleukin-6 deficiency increases inflammatory bone destruction | Q28587986 | ||
| Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes | Q33804742 | ||
| Proinflammatory effects of IL-10 during human endotoxemia | Q33914291 | ||
| Biology of interleukin-10. | Q34152272 | ||
| Bone involvement in sickle cell disease. | Q34416473 | ||
| Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis | Q34554218 | ||
| In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis | Q34759478 | ||
| Dilemma in differentiating between acute osteomyelitis and bone infarction in children with sickle cell disease: the role of ultrasound | Q34765997 | ||
| Interleukin-10 inhibits gram-negative-microbe-specific human receptor activator of NF-kappaB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo | Q34975683 | ||
| Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue | Q35097461 | ||
| IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology | Q35640443 | ||
| Musculoskeletal manifestations of sickle cell disease | Q36874512 | ||
| Interleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis. | Q36914413 | ||
| Influence of interleukin 1alpha (IL-1alpha), IL-4, and IL-6 polymorphisms on genetic susceptibility to chronic osteomyelitis | Q36994279 | ||
| Musculoskeletal manifestations of sickle cell anaemia: a pictorial review | Q37864933 | ||
| Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus | Q37957607 | ||
| Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia | Q37983011 | ||
| Sickle cell disease: time for a closer look at treatment options? | Q38114921 | ||
| Sickle cell disease in children: differentiating osteomyelitis from vaso-occlusive crisis | Q40395921 | ||
| Evidence for HLA class II susceptible and protective haplotypes for osteomyelitis in pediatric patients with sickle cell anemia | Q44319077 | ||
| Distinct cytokine profiles of circulating mononuclear cells stimulated with Staphylococcus aureus enterotoxin A in vitro during early and late episodes of chronic osteomyelitis | Q47891885 | ||
| Current bacterial causes of osteomyelitis in children with sickle cell disease | Q50056968 | ||
| Local and systemic concentrations of tumour necrosis factor-alpha, interleukin-6 and interleukin-8 in bacterial osteomyelitis | Q50120294 | ||
| IL-1α (− 889) promoter polymorphism is a risk factor for osteomyelitis | Q62269692 | ||
| Local and systemic inflammatory mediator release in patients with acute and chronic posttraumatic osteomyelitis | Q71002053 | ||
| Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10 | Q71698221 | ||
| Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms | Q72167883 | ||
| Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis | Q72871565 | ||
| IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo | Q73084702 | ||
| Taking critical appraisal to extremes. The need for balance in the evaluation of evidence | Q73331975 | ||
| Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells | Q74411962 | ||
| Local levels of interleukin-1beta, -4, -6 and tumor necrosis factor alpha in an experimental model of murine osteomyelitis due to staphylococcus aureus | Q74619347 | ||
| Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis | Q77902155 | ||
| Interleukin-10-induced CD8 cell proliferation | Q78197542 | ||
| Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis | Q80080932 | ||
| Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease | Q87661796 | ||
| P433 | issue | 9 | |
| P921 | main subject | sickle-cell disease | Q185034 |
| osteomyelitis | Q938983 | ||
| P304 | page(s) | 1020-1024 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease | |
| P478 | volume | 22 |
| Q38759245 | Arctigenin Confers Neuroprotection Against Mechanical Trauma Injury in Human Neuroblastoma SH-SY5Y Cells by Regulating miRNA-16 and miRNA-199a Expression to Alleviate Inflammation |
| Q38747005 | Interleukin-10 haplotypes are not associated with acute cerebral ischemia or high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia |
| Q64245170 | The challenge of differentiating vaso-occlusive crises from osteomyelitis in children with sickle cell disease and bone pain: A 15-year retrospective review |
Search more.